INVESTIGATING THE IMPACT OF VARIOUS TKI DRUGS ON ABSORBED RADIATION DOSE
Turkish Physical Society 40th International Physics Congress, Muğla, Türkiye, 2 - 06 Eylül 2024, ss.310, (Özet Bildiri)
- Yayın Türü: Bildiri / Özet Bildiri
- Basıldığı Şehir: Muğla
- Basıldığı Ülke: Türkiye
- Sayfa Sayıları: ss.310
- İstanbul Üniversitesi Adresli: Evet
Özet
The primary objective of this study is to investigate the relation between Tyrosine
Kinase Inhibitors and dose enhancement factors (DEF). The Monte Carlo N-Particle
(MCNP) Transport Code version 6.2 was employed to simulate the interactions of
photons with TKIs across a range of energy levels. Through MCNP, detailed
evaluations of photon transport, dose deposition, and interaction probabilities within
thyroid tumors were conducted. This computational method offered valuable
insights into how various photon energies and TKI types affect DEF, which is
essential for optimizing radiotherapy outcomes. Although the simulations provided
robust models of photon interactions, they may not fully capture the complexities of
biological systems. Challenges such as variable drug distribution within patients and
tumor heterogeneity must be considered when applying simulation results to clinical
scenarios. Future research should focus on validating these findings through clinical
trials and refining dosimetric models to incorporate patient-specific variables. By
clarifying the interactions between TKIs and radiotherapy, subsequent studies could
advance personalized treatment strategies, ultimately improving outcomes for
patients with thyroid cancer.